Related Experiment Video
Updated: Jun 27, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis
Kathleen Klotz1, Diana Cepeda, Yingmeei Tan
1Sidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, CA 92121, USA.
Abstract:
E-type cyclins (E1 and E2) regulate the S phase program in the mammalian cell division cycle. Expression of cyclin E1 and E2 is frequently deregulated in a variety of cancer types and a wealth of experimental evidence supports an oncogenic role of these proteins in human tumorigenesis. Although the molecular mechanisms responsible for cyclin E1 deregulation in cancer are well defined, little is known regarding cyclin E2. Here we report that cyclin E2 is targeted for ubiquitin-dependent proteolysis by the ubiquitin ligase SCF(Fbxw7/hCdc4). Ubiquitylation is triggered by phosphorylation of cyclin E2 on residues Thr392 and Ser396, and to a lesser extent Thr74, contained in two consensus Cdc4-phosphodegrons. Furthermore, we found that ectopic expression of cyclin E1 enhances the ubiquitin-dependent proteolysis of cyclin E2 in vivo, suggesting a potential cross-talk in the regulation of E-type cyclin activity. Since SCF(Fbxw7/hCdc4) is functionally inactivated in several human cancer types, alteration of this molecular pathway could contribute to the deregulation of cyclin E2 in tumorigenesis.
Insights
Cyclin E2 is degraded by the SCF(Fbxw7/hCdc4) ubiquitin ligase, a process crucial for cell cycle regulation. This pathway
Area of Science:
- Cell Biology
- Molecular Oncology
- Protein Degradation
Background:
- E-type cyclins (E1 and E2) are key regulators of the S phase in the cell division cycle.
- Deregulation of cyclin E1 and E2 expression is common in various cancers, indicating an oncogenic role.
- While cyclin E1 deregulation mechanisms are understood, those for cyclin E2 remain largely unknown.
Purpose of the Study:
- To elucidate the molecular mechanisms governing cyclin E2 regulation and degradation.
- To investigate the role of ubiquitin-dependent proteolysis in controlling cyclin E2 levels.
- To explore potential cross-talk between cyclin E1 and cyclin E2 regulation.
Main Methods:
- Investigated the targeting of cyclin E2 by the ubiquitin ligase SCF(Fbxw7/hCdc4).
- Analyzed the role of specific phosphorylation sites (Thr392, Ser396, Thr74) in triggering ubiquitylation.
- Examined the effect of ectopic cyclin E1 expression on cyclin E2 proteolysis in vivo.
Main Results:
- Cyclin E2 is specifically targeted for ubiquitin-dependent proteolysis by the SCF(Fbxw7/hCdc4) complex.
- Phosphorylation of cyclin E2 at Thr392 and Ser396 sites initiates its ubiquitylation and degradation.
- Ectopic expression of cyclin E1 enhances cyclin E2 proteolysis, suggesting regulatory cross-talk.
Conclusions:
- The SCF(Fbxw7/hCdc4) ligase controls cyclin E2 stability through phosphorylation-dependent degradation.
- This pathway represents a novel mechanism for regulating E-type cyclin activity.
- Functional inactivation of SCF(Fbxw7/hCdc4) in cancers may contribute to cyclin E2 deregulation and tumorigenesis.
Related Concept Videos
Anaphase Promoting Complex
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Positive Regulator Molecules
Positive Regulator Molecules
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...

